Informations:
Erreur:
ID
35055
Description
Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02483767
Lien
https://clinicaltrials.gov/show/NCT02483767
Mots-clés
Versions (1)
- 12/02/2019 12/02/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
12 février 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT02483767
Eligibility Breast Cancer NCT02483767
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT02483767
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Informed Consent
Item
the patients signed the written informed consent.
boolean
C0021430 (UMLS CUI [1])
Breast Carcinoma TNM Breast tumor staging
Item
histologically proven stage i, ii, or iii breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,2])
Patients Appropriate Adjuvant Chemotherapy | Patients Appropriate Chemotherapy Neoadjuvant
Item
must be candidates for adjuvant or neoadjuvant chemotherapy,
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1548787 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C1298676 (UMLS CUI [2,4])
C1548787 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1548787 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C1298676 (UMLS CUI [2,4])
Premenopausal state
Item
must be premenopausal.
boolean
C0232969 (UMLS CUI [1])
trastuzumab | Tumor HER2 Overexpression
Item
trastuzumab is permitted in patients with human epidermal growth factor receptor 2 (her2) overexpressing tumors.
boolean
C0728747 (UMLS CUI [1])
C0027651 (UMLS CUI [2,1])
C0069515 (UMLS CUI [2,2])
C1514559 (UMLS CUI [2,3])
C0027651 (UMLS CUI [2,1])
C0069515 (UMLS CUI [2,2])
C1514559 (UMLS CUI [2,3])
Prior Chemotherapy
Item
the patients were previous chemotherapy;
boolean
C1514457 (UMLS CUI [1])
Distant metastasis
Item
evidence of distant metastases;
boolean
C1269798 (UMLS CUI [1])
Cancer Other
Item
other malignancies in the previous 5 years.
boolean
C1707251 (UMLS CUI [1])
Gonadotropin releasing hormone agonists (GNRH-A) | Progesterone | Ovulation Stimulation Drugs | Contraceptives, Oral | Aromatase Inhibitors | Intrauterine Devices Hormonal | Subcutaneous contraceptive | Hormone Therapy Drugs
Item
the patients were using gnrha, progesterone, stimulate ovulation drugs, oral contraceptives, aromatase inhibitors, intrauterine device with hormone, subcutaneous preparations contraceptive drugs such as hormone drugs and instruments during 3 month preceding the start of chemotherapy.
boolean
C2012324 (UMLS CUI [1])
C0033308 (UMLS CUI [2])
C0029965 (UMLS CUI [3,1])
C1292856 (UMLS CUI [3,2])
C0013227 (UMLS CUI [3,3])
C0009905 (UMLS CUI [4])
C0593802 (UMLS CUI [5])
C0021900 (UMLS CUI [6,1])
C0458083 (UMLS CUI [6,2])
C0459222 (UMLS CUI [7])
C0279025 (UMLS CUI [8,1])
C0013227 (UMLS CUI [8,2])
C0033308 (UMLS CUI [2])
C0029965 (UMLS CUI [3,1])
C1292856 (UMLS CUI [3,2])
C0013227 (UMLS CUI [3,3])
C0009905 (UMLS CUI [4])
C0593802 (UMLS CUI [5])
C0021900 (UMLS CUI [6,1])
C0458083 (UMLS CUI [6,2])
C0459222 (UMLS CUI [7])
C0279025 (UMLS CUI [8,1])
C0013227 (UMLS CUI [8,2])
Pregnancy | Breast Feeding
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])